Last reviewed · How we verify
Telitacicept Freeze-dried powder Injection 80mg
Telitacicept Freeze-dried powder Injection 80mg is a Small molecule drug developed by RemeGen Co., Ltd.. It is currently FDA-approved.
Telitacicept is a protein-based injection used in the treatment of certain conditions, including Lupus or SLE and Interstitial Lung Disease. It is administered as a freeze-dried powder injection, 80mg in dose.
At a glance
| Generic name | Telitacicept Freeze-dried powder Injection 80mg |
|---|---|
| Sponsor | RemeGen Co., Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease (PHASE4)
- A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Telitacicept Freeze-dried powder Injection 80mg CI brief — competitive landscape report
- Telitacicept Freeze-dried powder Injection 80mg updates RSS · CI watch RSS
- RemeGen Co., Ltd. portfolio CI
Frequently asked questions about Telitacicept Freeze-dried powder Injection 80mg
What is Telitacicept Freeze-dried powder Injection 80mg?
Who makes Telitacicept Freeze-dried powder Injection 80mg?
What development phase is Telitacicept Freeze-dried powder Injection 80mg in?
Related
- Manufacturer: RemeGen Co., Ltd. — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing